Mode
Text Size
Log in / Sign up
N/A N=194 Randomized Double-blind Treatment

RCT of Brief CBT-I in Primary Care Veterans With Suicidal Thoughts

Insomnia · Suicidal Ideation

Enrolled (actual)
194
Serious AEs
3.6%
Results posted
Jun 2024
Primary outcome: Primary: Insomnia Severity Index Change — 8.54; 11.88 score on a scale — p=<0.01

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive Behavioral Therapy for Insomnia (Behavioral); Sleep Hygiene (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Dec 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Insomnia Severity Index Change
8.54; 11.88 <0.01 sig
SECONDARY
Scale for Suicidal Ideation Change
1.08; 3.10 0.03 sig
SECONDARY
PTSD Symptom Checklist-DSM 5 Change
29.68; 29.94 0.84
SECONDARY
Patient Health Questionnaire-Depression Change
8.92; 11.33 0.01 sig

Summary

There is a strong association between insomnia and suicidal thoughts and behaviors. Insomnia also frequently co-occurs with other common conditions associated with suicide such as depression and posttraumatic stress disorder. This project focuses on improving sleep as a novel suicide prevention strategy that can be delivered to a broad range of Veterans. The study will examine how Cognitive Behavioral Therapy for Insomnia, an efficacious treatment for insomnia, may reduce suicidal thoughts in Veterans who also suffer from co-occurring conditions when delivered by integrated primary care clinicians.

Eligibility Criteria

Inclusion Criteria

  • English speaking
  • Veteran seeking or receiving services at the Canandaigua, Buffalo or Syracuse VA Medical Centers
  • Demonstrate understanding of informed consent
  • Endorse current death/suicidal ideation on item 9 of the Patient Health Questionnaire-9
  • An Insomnia Severity Index score > 10 with trouble sleeping 3 months and at least 1 insomnia-related daytime consequence
  • Either:
  • [a] a current diagnosis of Major Depressive Disorder, Depression not otherwise specified or PTSD
  • [b] a score of > 16 on the Patient Health Questionnaire for Depression (PHQ-9) or a score > 46 on the PTSD Symptom Checklist
  • If using psychotropic medications the dosage must be stable

Exclusion Criteria

  • History of serious mental illness such as schizophrenia, Bipolar I or II disorder, or current psychiatric conditions such as psychosis, mania, dementia or cognitive impairment
  • A suicide attempt within the last 6 months or [report of SI with active plan or intent in the past month]
  • Currently engaged in inpatient or partial hospitalization programs
  • Recent substance dependence disorder with < 6 months abstinence
  • Narcolepsy
  • Circadian rhythm disorders
  • Restless legs syndrome
  • Untreated sleep apnea based upon chart review
  • A sleep disorders screening questionnaire and the STOP-BANG sleep apnea questionnaire
  • Sleep medications are not exclusionary, but participants using them must still meet insomnia criteria
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03603717). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search